Tc-99m sestamibi infarct size as a surrogate endpoint.
Gibbons
Raymond J
RJ
Miller
Todd D
TD
D015415:Biomarkers / Q000378:metabolism; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012720:Severity of Illness Index; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics; D016896:Treatment Outcome
D015415:Biomarkers; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi